CAPR Earnings

Quarterly EPS
$-0.35
Q2 2024
$-0.38
Q3 2024
$-0.16
Q4 2024
$-0.53
Q1 2025
$-0.57
Q2 2025
$-0.54
Q3 2025
$-0.62
Q4 2025
$-0.59
Q1 2026
Latest RevenueN/A
Latest Net Income-33941345
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q1 2026-$0.590-33941345-11.3%
Q4 2025-$0.620-30170914-100.0%-287.5%
Q3 2025-$0.540-24570647-100.0%-42.1%
Q2 2025-$0.570-25910791-100.0%-62.9%
Q1 2025-$0.530-24391594-100.0%-71.0%
Q4 2024-$0.1611.1M-7116603-7.9%-700.0%
Q3 2024-$0.382.3M-12556728-63.4%-52.0%
Q2 2024-$0.354.0M-10999782+1.4%-20.7%
Q1 2024-$0.314.9M-9794073
Q4 2023-$0.0212.1M-762089
Q3 2023-$0.256.2M-6390608
Q2 2023-$0.293.9M-7366579
Capricor Therapeutics (CAPR) — Earnings